Biweekly Pegylated Liposomal Doxorubicin in Heavily Pretreated Patients With Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer